Skip to main content

Table 1 The basic information of 90 patients with HCC

From: TM4SF1 upregulates MYH9 to activate the NOTCH pathway to promote cancer stemness and lenvatinib resistance in HCC

Clinicopathological features

Number

Low expression, N (%)

High expression, N (%)

P value

Age

≤ 50

31

23

8

0.5292

> 50

59

40

19

 

Gender

Male

74

53

21

0.5503

Female

16

10

6

 

Tumor size

≤ 5 cm

44

37

7

0.0043**

> 5 cm

46

26

20

 

Edmondson’s grade

I

21

20

1

0.0039**

II–III

69

43

26

 

T grade

T1–T2

52

36

16

0.8516

T3–T4

38

27

11

 

Cirrhosis

Negative

73

55

18

0.0219*

Positive

17

8

19

 

Pathological morphology

Nodular type

54

37

17

0.7073

Massive type

36

26

10

 
  1. *P < 0.05 **P < 0.005